Exosome in Alzheimer's Disease
Exosome in Alzheimer's Disease
Exosomes produced by mesenchymal stem cells (MSCs) have demonstrated neuroprotective qualities. In clinical settings, these exosomes can enhance cognitive performance and slow the accumulation of amyloid-β plaques, a hallmark of Alzheimer's disease. This suggests that exosome-based therapies might offer a viable option for halting or even reversing Alzheimer's progression.